ArticleCancer science2013

Sustained upregulation of effector natural killer cells in chronic myeloid leukemia after discontinuation of imatinib.

Izuru Mizoguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.